Abacus dx is pleased to have recently partnered with a US based company – T2 Biosystems,
Cell and gene therapies require development of fit for purpose analytical tools to support bioprocess development, for biopharmaceutical characterization and lot release testing.
Webinar: Development of sensitive ADA assays using automated acid dissociation in Gyrolab Mixing CD 96
Measuring Anti-Drug-Antibody (ADA) levels is an important part of developing new biologics. The clinical implication of the presence of anti-drug-antibodies in treated patients may include allergic reactions, immune complex toxicity, autoimmune reactions and reduction of efficacy.
Multiplex assays of the anti-apoptotic BCL-2 family
A hallmark of cancer cells is defects in the apoptotic cell death program.